Barry Shin - 09 Dec 2024 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role: CFO
Signature: /s/ Neil Lerner, Attorney-in-fact
Issuer symbol: CMPX
Transactions as of: 09 Dec 2024
Net transactions value: +$660,000
Form type: 4
Filing time: 10 Dec 2024, 14:02:28 UTC
Previous filing: 10 Oct 2024
Next filing: 13 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMPX	Common Stock	Award	$660,000	+400,000		$1.65	400,000	09 Dec 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMPX	Stock Option (Right to Buy)	Award	$0	+400,000		$0.000000	400,000	09 Dec 2024	Common Stock	400,000	$1.65	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSU") granted to the reporting person on December 9, 2024. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vesting on December 9, 2025.
F2	The options vest as follows: 25% on December 9, 2025, with the remaining over 36 substantially equal monthly installments starting January 9, 2026.